Follow
Katleen De Preter
Katleen De Preter
post-doctoral researcher, Ghent University
Verified email at ugent.be
Title
Cited by
Cited by
Year
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
J Vandesompele, K De Preter, F Pattyn, B Poppe, N Van Roy, ...
Genome biology 3 (7), 1-12, 2002
194052002
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification
S De Brouwer, K De Preter, C Kumps, P Zabrocki, M Porcu, ...
Clinical cancer research 16 (17), 4353-4362, 2010
2932010
Mutational dynamics between primary and relapse neuroblastomas
A Schramm, J Köster, Y Assenov, K Althoff, M Peifer, E Mahlow, ...
Nature genetics 47 (8), 872-877, 2015
2822015
Evaluation of qPCR curve analysis methods for reliable biomarker discovery: bias, resolution, precision, and implications
JM Ruijter, MW Pfaffl, S Zhao, AN Spiess, G Boggy, J Blom, RG Rutledge, ...
Methods 59 (1), 32-46, 2013
2482013
Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay
K De Preter, F Speleman, V Combaret, J Lunec, G Laureys, BHJ Eussen, ...
Modern Pathology 15 (2), 159-166, 2002
1962002
Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma
J Vandesompele, M Baudis, K De Preter, N Van Roy, P Ambros, N Bown, ...
Journal of Clinical Oncology 23 (10), 2280-2299, 2005
1942005
Measurable impact of RNA quality on gene expression results from quantitative PCR
J Vermeulen, K De Preter, S Lefever, J Nuytens, F De Vloed, S Derveaux, ...
Nucleic acids research 39 (9), e63-e63, 2011
1902011
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
J Vermeulen, K De Preter, A Naranjo, L Vercruysse, N Van Roy, ...
The lancet oncology 10 (7), 663-671, 2009
1852009
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
K De Preter, J Vandesompele, P Heimann, N Yigit, S Beckman, ...
Genome biology 7 (9), 1-17, 2006
1762006
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice
LC Heukamp, T Thor, A Schramm, K De Preter, C Kumps, B De Wilde, ...
Science translational medicine 4 (141), 141ra91-141ra91, 2012
1652012
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours
P Mestdagh, E Fredlund, F Pattyn, A Rihani, T Van Maerken, J Vermeulen, ...
Oncogene 29 (24), 3583-3592, 2010
1612010
Asthma inflammatory phenotypes show differential microRNA expression in sputum
T Maes, FA Cobos, F Schleich, V Sorbello, M Henket, K De Preter, ...
Journal of Allergy and Clinical Immunology 137 (5), 1433-1446, 2016
1582016
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
P Mestdagh, E Fredlund, F Pattyn, JH Schulte, D Muth, J Vermeulen, ...
Oncogene 29 (9), 1394-1404, 2010
1442010
Targeting MYCN-driven transcription by BET-bromodomain inhibition
A Henssen, K Althoff, A Odersky, A Beckers, R Koche, F Speleman, ...
Clinical Cancer Research 22 (10), 2470-2481, 2016
1362016
Computational deconvolution of transcriptomics data from mixed cell populations
F Avila Cobos, J Vandesompele, P Mestdagh, K De Preter
Bioinformatics 34 (11), 1969-1979, 2018
1352018
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma
JH Schulte, HS Bachmann, B Brockmeyer, K DePreter, A Oberthür, ...
Clinical Cancer Research 17 (15), 5082-5092, 2011
1162011
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
JH Schulte, B Schowe, P Mestdagh, L Kaderali, P Kalaghatgi, S Schlierf, ...
International Journal of Cancer 127 (10), 2374-2385, 2010
1092010
arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays
B Menten, F Pattyn, K De Preter, P Robbrecht, E Michels, K Buysse, ...
BMC bioinformatics 6 (1), 1-9, 2005
1092005
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells
JH Schulte, S Lindner, A Bohrer, J Maurer, K De Preter, S Lefever, ...
Oncogene 32 (8), 1059-1065, 2013
1082013
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
DR Carter, J Murray, BB Cheung, L Gamble, J Koach, J Tsang, S Sutton, ...
Science translational medicine 7 (312), 312ra176-312ra176, 2015
1022015
The system can't perform the operation now. Try again later.
Articles 1–20